European Companies Search Engine

Santen Pharmaceutical Co. Ltd., Osaka, Japan

Name

Santen Pharmaceutical Co. Ltd.
参天製薬株式会社 株

Identification

Stockp
SNPHY
Stockp
SNPHF

Address

Corporate purpose

Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that is in Phase III clinical trial … Show more

Financials

History

Network

Loading network

Annual report

Publications

Year 2022 in Euipods
Year 2019 in Euipods
Year 2018 in Euipods
Year 2017 in Euipods
There are no publications matching your search.

Mentions

There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Santen Pharmaceutical Co. Ltd., Osaka, Japan" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.